Zacks.com on MSN5mon
Insmed Stock Surges 168% in the Past Six Months: Here's WhyThe surge in stock price can be attributed to the company’s progress with its two pipeline candidates, brensocatib and ...
Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback